Clinicopathological Reclassification of Idiopathic Inflammatory Myopathy to Match the Serological Results of Myositis-Specific Antibodies

CONCLUSIONS: This new clinicopathological classification for IIM in combination with serological test results could be applied to our previous case series. Adoption of the new criteria will lead to a better understanding of the disease and hence new therapeutic insights.PMID:38179634 | PMC:PMC10782087 | DOI:10.3988/jcn.2022.0432

Source: Journal of Clinical Neurology - January 5, 2024 Category: Neurology Authors: Young-Eun Park Dae-Seong Kim Minsung Kang Jin-Hong Shin Source Type: research